{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T22:14:26Z","timestamp":1769811266537,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005727","name":"Universidade de Coimbra","doi-asserted-by":"publisher","award":["PT0056.A.02"],"award-info":[{"award-number":["PT0056.A.02"]}],"id":[{"id":"10.13039\/501100005727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["EXPL\/MEC-NEU\/0192\/2021"],"award-info":[{"award-number":["EXPL\/MEC-NEU\/0192\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34241-7","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T23:52:00Z","timestamp":1768434720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma p-tau217, quantified by the fully automated LUMIPULSE G platform, outperforms p-tau181 in predicting amyloid pathology in cognitive complaints patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Anuschka","family":"Silva-Sp\u00ednola","sequence":"first","affiliation":[]},{"given":"Jo\u00e3o","family":"Dur\u00e3es","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o Pedro Guedes","family":"de Oliveira","sequence":"additional","affiliation":[]},{"given":"Miguel","family":"T\u00e1buas-Pereira","sequence":"additional","affiliation":[]},{"given":"Marisa","family":"Lima","sequence":"additional","affiliation":[]},{"given":"Alexandre","family":"de Mendon\u00e7a","sequence":"additional","affiliation":[]},{"given":"Isabel","family":"Santana","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Baldeiras","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"34241_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert, M. S. et al. The diagnosis of mild cognitive impairment due to alzheimer\u2019s disease: recommendations from the National Institute on Aging\u2013Alzheimer\u2019s association workgroups. Alzheimers Dement. 7, 270\u2013279 (2011).","journal-title":"Alzheimers Dement."},{"key":"34241_CR2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/joim.12816","volume":"284","author":"K Blennow","year":"2018","unstructured":"Blennow, K. & Zetterberg, H. Biomarkers for alzheimer\u2019s disease: current status and prospects for the future. J. Intern. Med. 284, 643\u2013663 (2018).","journal-title":"J. Intern. Med."},{"key":"34241_CR3","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of alzheimer\u2019s disease. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"34241_CR4","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1001\/jamaneurol.2024.3770","volume":"81","author":"B Dubois","year":"2024","unstructured":"Dubois, B. et al. Alzheimer disease as a clinical-biological construct. JAMA Neurol. 81, 1304\u20131311 (2024).","journal-title":"JAMA Neurol."},{"key":"34241_CR5","doi-asserted-by":"publisher","first-page":"e70535","DOI":"10.1002\/alz.70535","volume":"21","author":"S Palmqvist","year":"2025","unstructured":"Palmqvist, S. et al. Alzheimer\u2019s association clinical practice guideline on the use of blood-based biomarkers in the diagnostic workup of suspected alzheimer\u2019s disease. Alzheimers Dement. 21, e70535 (2025).","journal-title":"Alzheimers Dement."},{"key":"34241_CR6","doi-asserted-by":"publisher","first-page":"e17123","DOI":"10.15252\/emmm.202217123","volume":"15","author":"G Salvad\u00f3","year":"2023","unstructured":"Salvad\u00f3, G. et al. Specific associations between plasma biomarkers and postmortem amyloid plaque and Tau tangle loads. EMBO Mol. Med. 15, e17123 (2023).","journal-title":"EMBO Mol. Med."},{"key":"34241_CR7","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1001\/jama.2020.12134","volume":"324","author":"S Palmqvist","year":"2020","unstructured":"Palmqvist, S. et al. Discriminative accuracy of plasma phospho-tau217 for alzheimer disease versus other neurodegenerative disorders. JAMA 324, 772\u2013781 (2020).","journal-title":"JAMA"},{"key":"34241_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S1474-4422(21)00214-3","volume":"20","author":"EH Thijssen","year":"2021","unstructured":"Thijssen, E. H. et al. Plasma phosphorylated Tau 217 and 181 as biomarkers in alzheimer\u2019s disease and frontotemporal Lobar degeneration. Lancet Neurol. 20, 739\u2013752 (2021).","journal-title":"Lancet Neurol."},{"key":"34241_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton, N. J. et al. Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for alzheimer disease pathology. JAMA Neurol. 81, 255\u2013263 (2024).","journal-title":"JAMA Neurol."},{"key":"34241_CR10","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s43587-025-00835-z","volume":"5","author":"R Ossenkoppele","year":"2025","unstructured":"Ossenkoppele, R. et al. Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals. Nat. Aging. 5, 883\u2013896 (2025).","journal-title":"Nat. Aging"},{"key":"34241_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s13195-024-01513-9","volume":"16","author":"J Arranz","year":"2024","unstructured":"Arranz, J. et al. Diagnostic performance of plasma pTau217, pTau181, A\u03b21\u201342 and A\u03b21\u201340 in the LUMIPULSE automated platform for the detection of alzheimer disease. Alzheimers Res. Ther. 16, 139 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"34241_CR12","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41591-025-03622-w","volume":"31","author":"S Palmqvist","year":"2025","unstructured":"Palmqvist, S. et al. Plasma phospho-tau217 for alzheimer\u2019s disease diagnosis in primary and secondary care using a fully automated platform. Nat. Med. 31, 2036\u20132043 (2025).","journal-title":"Nat. Med."},{"key":"34241_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen, C. E. et al. Blood-based biomarkers for alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 21, 66\u201377 (2022).","journal-title":"Lancet Neurol."},{"key":"34241_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jamaneurol.2023.0199","volume":"80","author":"S Janelidze","year":"2023","unstructured":"Janelidze, S. et al. Mitigating the associations of kidney dysfunction with blood biomarkers of alzheimer disease by using phosphorylated Tau to total Tau ratios. JAMA Neurol. 80, 516\u2013522 (2023).","journal-title":"JAMA Neurol."},{"key":"34241_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/archinte.163.3.356","volume":"163","author":"PJ Swedko","year":"2003","unstructured":"Swedko, P. J., Clark, H. D., Paramsothy, K. & Akbari, A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch. Intern. Med. 163, 356\u2013360 (2003).","journal-title":"Arch. Intern. Med."},{"key":"34241_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2021.08.011","volume":"333","author":"R Peng","year":"2021","unstructured":"Peng, R. et al. Blood Urea nitrogen, blood Urea nitrogen to creatinine ratio and incident stroke. Atherosclerosis 333, 1\u20138 (2021).","journal-title":"Atherosclerosis"},{"key":"34241_CR17","doi-asserted-by":"publisher","first-page":"100629","DOI":"10.1016\/j.mcpro.2023.100629","volume":"22","author":"CE Teunissen","year":"2023","unstructured":"Teunissen, C. E. et al. Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias. Mol. Cell. Proteom. 22, 100629 (2023).","journal-title":"Mol. Cell. Proteom."},{"key":"34241_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/brain\/awae368","volume":"148","author":"A Pilotto","year":"2025","unstructured":"Pilotto, A. et al. Plasma p-tau217 in alzheimer\u2019s disease: lumipulse and ALZpath SIMOA head-to-head comparison. Brain 148, 408\u2013415 (2025).","journal-title":"Brain"},{"key":"34241_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13195-019-0550-8","volume":"11","author":"MJ Leit\u00e3o","year":"2019","unstructured":"Leit\u00e3o, M. J. et al. Clinical validation of the lumipulse G cerebrospinal fluid assays for routine diagnosis of alzheimer\u2019s disease. Alzheimers Res. Ther. 11, 91 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"34241_CR20","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/brain\/awac333","volume":"146","author":"S Janelidze","year":"2023","unstructured":"Janelidze, S. et al. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal alzheimer\u2019s disease. Brain 146, 1592\u20131601 (2023).","journal-title":"Brain"},{"key":"34241_CR21","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00415-023-12148-5","volume":"271","author":"AJ Mendes","year":"2024","unstructured":"Mendes, A. J. et al. Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231. J. Neurol. 271, 2053\u20132066 (2024).","journal-title":"J. Neurol."},{"key":"34241_CR22","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13195-024-01630-5","volume":"16","author":"AL Wojda\u0142a","year":"2024","unstructured":"Wojda\u0142a, A. L. et al. Analytical and clinical performance of eight automated assays for plasma p-tau181 and p-tau217. Alzheimers Res. Ther. 16, 266 (2024).","journal-title":"Alzheimers Res. Ther."},{"key":"34241_CR23","doi-asserted-by":"publisher","first-page":"e70080","DOI":"10.1002\/dad2.70080","volume":"17","author":"AH Dyer","year":"2025","unstructured":"Dyer, A. H. et al. Clinical performance of the fully automated lumipulse plasma p-tau217 assay in mild cognitive impairment and mild dementia. Alzheimers Dement. (Amst). 17, e70080 (2025).","journal-title":"Alzheimers Dement. (Amst)"},{"key":"34241_CR24","doi-asserted-by":"publisher","first-page":"105405","DOI":"10.1016\/j.ebiom.2024.105405","volume":"109","author":"A Feizpour","year":"2024","unstructured":"Feizpour, A. et al. Detection and staging of alzheimer\u2019s disease by plasma pTau217 on a high-throughput immunoassay platform. EBioMedicine 109, 105405 (2024).","journal-title":"EBioMedicine"},{"key":"34241_CR25","doi-asserted-by":"publisher","first-page":"6506","DOI":"10.1002\/alz.14140","volume":"20","author":"DJ Figdore","year":"2024","unstructured":"Figdore, D. J. et al. Optimizing cutpoints for clinical interpretation of brain amyloid status using plasma p-tau217 immunoassays. Alzheimers Dement. 20, 6506\u20136516 (2024).","journal-title":"Alzheimers Dement."},{"key":"34241_CR26","doi-asserted-by":"publisher","first-page":"e70316","DOI":"10.1002\/alz.70316","volume":"21","author":"YD Piura","year":"2025","unstructured":"Piura, Y. D. et al. Diagnostic performance of plasma p-tau217 and A\u03b242\/40 biomarkers in the outpatient memory clinic. Alzheimers Dement. 21, e70316 (2025).","journal-title":"Alzheimers Dement."},{"key":"34241_CR27","doi-asserted-by":"publisher","first-page":"6739","DOI":"10.1007\/s00415-024-12631-7","volume":"271","author":"G Cecchetti","year":"2024","unstructured":"Cecchetti, G. et al. Diagnostic accuracy of automated lumipulse plasma pTau-217 in alzheimer\u2019s disease. J. Neurol. 271, 6739\u20136749 (2024).","journal-title":"J. Neurol."},{"key":"34241_CR28","doi-asserted-by":"publisher","first-page":"e70116","DOI":"10.1002\/dad2.70116","volume":"17","author":"G Giacomucci","year":"2025","unstructured":"Giacomucci, G. et al. The two cut-offs approach for plasma p-tau217 in detecting alzheimer\u2019s disease. Alzheimers Dement. (Amst). 17, e70116 (2025).","journal-title":"Alzheimers Dement. (Amst)"},{"key":"34241_CR29","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.14283\/jpad.2024.152","volume":"11","author":"F Mart\u00ednez-Dubarbie","year":"2024","unstructured":"Mart\u00ednez-Dubarbie, F. et al. Diagnostic accuracy of plasma p-tau217 for detecting pathological cerebrospinal fluid changes. J. Prev. Alzheimers Dis. 11, 1581\u20131591 (2024).","journal-title":"J. Prev. Alzheimers Dis."},{"key":"34241_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/s41582-024-00977-5","volume":"20","author":"SE Schindler","year":"2024","unstructured":"Schindler, S. E. et al. Acceptable performance of blood biomarker tests of amyloid pathology. Nat. Rev. Neurol. 20, 426\u2013439 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"34241_CR31","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3233\/JAD-215730","volume":"90","author":"TK Karikari","year":"2022","unstructured":"Karikari, T. K. Blood tests for alzheimer\u2019s disease: increasing efforts to expand and diversify research participation. J. Alzheimers Dis. 90, 967\u2013974 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"34241_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12911-017-0497-2","volume":"17","author":"T Pereira","year":"2017","unstructured":"Pereira, T. et al. Predicting progression of mild cognitive impairment to dementia using neuropsychological data. BMC Med. Inf. Decis. Mak. 17, 110 (2017).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"34241_CR33","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","volume":"10","author":"F Jessen","year":"2014","unstructured":"Jessen, F. et al. A conceptual framework for research on subjective cognitive decline in preclinical alzheimer\u2019s disease. Alzheimers Dement. 10, 844\u2013852 (2014).","journal-title":"Alzheimers Dement."},{"key":"34241_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1001\/archneur.56.3.303","volume":"56","author":"RC Petersen","year":"1999","unstructured":"Petersen, R. C. et al. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56, 303\u2013308 (1999).","journal-title":"Arch. Neurol."},{"key":"34241_CR35","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Publishing, 2013).","DOI":"10.1176\/appi.books.9780890425596"},{"key":"34241_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1186\/1756-0500-4-299","volume":"4","author":"J Maroco","year":"2011","unstructured":"Maroco, J. et al. Data mining methods in the prediction of dementia: A real-data comparison of the accuracy, sensitivity and specificity of linear discriminant analysis, logistic regression, neural networks, support vector machines, classification trees and random forests. BMC Res. Notes. 4, 299 (2011).","journal-title":"BMC Res. Notes"},{"key":"34241_CR37","doi-asserted-by":"publisher","first-page":"240","DOI":"10.20344\/amp.6889","volume":"29","author":"I Santana","year":"2016","unstructured":"Santana, I. et al. Mini-Mental state examination: screening and diagnosis of cognitive decline. Acta Med. Port. 29, 240\u2013248 (2016).","journal-title":"Acta Med. Port"},{"key":"34241_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2217\/bmm.12.46","volume":"6","author":"M del Campo","year":"2012","unstructured":"del Campo, M. et al. Recommendations to standardize preanalytical confounding factors in alzheimer\u2019s and parkinson\u2019s disease cerebrospinal fluid biomarkers: an update. Biomark. Med. 6, 419\u2013430 (2012).","journal-title":"Biomark. Med."},{"key":"34241_CR39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.jalz.2011.05.2243","volume":"7","author":"N Mattsson","year":"2011","unstructured":"Mattsson, N. et al. The alzheimer\u2019s association external quality control program for cerebrospinal fluid biomarkers. Alzheimers Dement. 7, 386\u2013395 (2011).","journal-title":"Alzheimers Dement."},{"key":"34241_CR40","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack, C. R. Jr. et al. NIA-AA research framework: toward a biological definition of alzheimer\u2019s disease. Alzheimers Dement. 14, 535\u2013562 (2018).","journal-title":"Alzheimers Dement."},{"key":"34241_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1515\/cclm-2021-0651","volume":"60","author":"J Gobom","year":"2021","unstructured":"Gobom, J. et al. Validation of the LUMIPULSE automated immunoassay for measurement of core alzheimer\u2019s disease biomarkers in cerebrospinal fluid. Clin. Chem. Lab. Med. 60, 207\u2013219 (2021).","journal-title":"Clin. Chem. Lab. Med."},{"key":"34241_CR42","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1093\/brain\/aww160","volume":"139","author":"A Leuzy","year":"2016","unstructured":"Leuzy, A. et al. Pittsburgh compound B imaging and cerebrospinal fluid amyloid-\u03b2 in a multicentre European memory clinic study. Brain 139, 2540\u20132553 (2016).","journal-title":"Brain"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34241-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34241-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34241-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T11:03:44Z","timestamp":1769771024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34241-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34241"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34241-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"10 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4133"}}